None of the 29 investors followed here reported a position in EMBC in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a EMBC trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Morris Milton MayoDirector | Sale at price 5.88 per share. | 6.3K | $36.97K |
| Aug 11, 2026 | Hombach Robert J. CpaDirector | Purchase at price 4.97 per share. | 45K | $223.85K |
| Aug 11, 2026 | Mann Jeffrey ZOfficer | Purchase at price 4.99 per share. | 20K | $99.80K |
| Aug 11, 2026 | Elguicze JacobOfficer | Purchase at price 4.67 per share. | 20K | $93.36K |
| Aug 11, 2026 | Kurdikar DevdattOfficer and Director | Purchase at price 4.70 per share. | 30K | $140.94K |
| May 31, 2026 | Roth Anthony M.Officer | Stock Award(Grant) at price 0.00 per share. | 30K | — |
| Feb 10, 2026 | Morris Milton MayoDirector | Stock Award(Grant) at price 0.00 per share. | 22.8K | — |
| Feb 10, 2026 | Hombach Robert J. CpaDirector | Stock Award(Grant) at price 0.00 per share. | 22.8K | — |
| Feb 10, 2026 | Prange Karen N.Director | Stock Award(Grant) at price 0.00 per share. | 22.8K | — |
| Feb 10, 2026 | Pomeroy ClaireDirector | Stock Award(Grant) at price 0.00 per share. | 22.8K | — |
| Feb 10, 2026 | Anderson Carrie LDirector | Stock Award(Grant) at price 0.00 per share. | 22.8K | — |
| Feb 10, 2026 | Reidy Christopher RDirector | Stock Award(Grant) at price 0.00 per share. | 22.8K | — |
| Nov 25, 2025 | Casner JeanOfficer | Stock Award(Grant) at price 0.00 per share. | 38.8K | — |
| Nov 25, 2025 | Mann Jeffrey ZGeneral Counsel | Stock Award(Grant) at price 0.00 per share. | 104K | — |
| Nov 25, 2025 | Elguicze JacobChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 125.6K | — |
| Nov 25, 2025 | Kurdikar DevdattChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 392K | — |
| Nov 25, 2025 | Curtis ShaunOfficer | Stock Award(Grant) at price 0.00 per share. | 49.1K | — |
| Nov 25, 2025 | Roth Anthony M.Officer | Stock Award(Grant) at price 0.00 per share. | 32.8K | — |
| May 22, 2025 | Melcher David F.Director | Purchase at price 10.60 per share. | 10K | $106.00K |
| Feb 24, 2025 | Melcher David F.Director | Purchase at price 13.67 per share. | 13K | $177.65K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -10.7 | -3.3 | -13.8 | 3.5 | -63.1 | -3.6 | 11.7 | 41.2 | 10.1 | 8.9 | −48.1% | ||
| 2025 | -13.2 | -24.7 | -5.6 | -4.4 | -13.6 | -8.0 | 4.9 | 42.5 | -2.6 | -5.5 | -4.4 | -6.9 | −42.5% |
| 2024 | -9.5 | -16.7 | -7.1 | -23.7 | 22.1 | 1.1 | 25.4 | 4.3 | -13.7 | -0.1 | 47.9 | -0.9 | +9.1% |
| 2023 | 4.3 | 21.1 | -12.0 | -1.3 | -0.3 | -21.9 | -1.2 | -14.1 | -17.9 | 0.5 | 21.3 | 3.2 | −25.1% |
| 2022 | -8.7 | -18.6 | 2.2 | 16.2 | 8.5 | -9.8 | 7.4 | 6.5 | -23.2 | −24.1% |
Buy / hold / sell counts
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.